[Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease]

Z Rheumatol. 2008 May;67(3):232-6. doi: 10.1007/s00393-008-0285-6.
[Article in German]

Abstract

In this report we present the 9-year course of disease in a woman of Turkish origin suffering from Behçet's disease with parenchymal CNS involvement combined with myalgia. Differential diagnoses, such as drug-induced neuromyopathy were excluded on the basis of electromyographic and bioptic tests. We were able to arrest progression of symptoms of both the myopathy and the Neuro-Behçet's disease by means of increased combined immunosuppressive therapy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use
  • Behcet Syndrome / diagnosis*
  • Behcet Syndrome / drug therapy
  • Behcet Syndrome / pathology
  • Biopsy
  • Brain Diseases / diagnosis*
  • Brain Diseases / drug therapy
  • Brain Diseases / pathology
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Electromyography
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / pathology
  • Neuromuscular Diseases / diagnosis*
  • Neuromuscular Diseases / drug therapy
  • Neuromuscular Diseases / pathology
  • Optic Neuritis / diagnosis*
  • Optic Neuritis / drug therapy
  • Optic Neuritis / pathology
  • Prednisone / adverse effects
  • Prednisone / therapeutic use
  • Uveitis, Posterior / diagnosis*
  • Uveitis, Posterior / drug therapy
  • Uveitis, Posterior / pathology

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Azathioprine
  • Prednisone